Journal: Cell Communication and Signaling : CCS
Article Title: Artificial intelligence-driven discovery of YH395A: A novel TGFβR1 inhibitor with potent anti-tumor activity against triple-negative breast cancer
doi: 10.1186/s12964-025-02337-2
Figure Lengend Snippet: YH395A inhibited breast cancer cell proliferation. (A) Breast cancer cell lines (MDA-MB-231, MDA-MB-468, BT549, SUM159, and BT-20), normal mammary epithelial cells (MCF-10 A), human gastric mucosal epithelial cells (GES-1), and human embryonic lung fibroblast cells (MRC-5) were treated with the indicated concentrations of YH395A or YR-290. After 96 h, SRB assay was performed. The bars indicate the mean ± SD. (B) Colony formation assays of breast cancer cells
Article Snippet: The MCF-10 A, GES-1, MRC-5, and triple-negative breast cancer (TNBC) cell lines BT549 (RRID: CVCL_0062), MDA-MB-468 (RRID: CVCL_0419), BT-20 (RRID: CVCL_0169), and MDA-MB-231(RRID: CVCL_0063) were sourced from the American Type Culture Collection (ATCC, USA), while SUM159 cells were generously donated by Dr. Yuzhu Zhang (Guangdong Academy of Chinese Medicine, China).
Techniques: Sulforhodamine B Assay